Blog

882 Articles

DNA helix made of multicolor dots on a bright blue background
Research
September 21, 2018 • 2 Min

Personalized Immunotherapy Vaccine for Pancreatic Cancer

Researchers are creating a personalized vaccine to stimulate a pancreatic cancer patient’s immune system after surgery and chemotherapy.

Biden Cancer Initiative logo and Let's Win logo
News
September 20, 2018 • 3 Min

Let’s Win Receives Biden Cancer Initiative FIERCE Award

Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”

Christine Shaffer pancreatic cancer patient, outside in the sunlight
Survivor Stories
September 17, 2018 • 4 Min

Failure is Not an Option

Christine Shaffer underwent chemotherapy and stereotactic body radiation therapy to shrink her tumor for surgery. She says failure is not an option.

laboratory glassware
Research
September 12, 2018 • 3 Min

Tough Tortoise of a Drug Beating Metastatic Pancreatic Cancer

Rexahn Pharmaceuticals is testing RX-3117, a slow-releasing drug similar to gemcitabine, in a clinical trial for metastatic pancreatic cancer patients.

Social worker E. Angela Heller
Disease Management
September 7, 2018 • 4 Min

Support Groups Provide an Emotional Lift

Social worker Angie Heller knows the value of pancreatic cancer support groups. She leads a group at Columbia University Medical Center’s Pancreas Center.

Brigitte Regnier and her husband read a book together while seated on a sofa.
Survivor Stories
September 4, 2018 • 5 Min

Picking the Right Team

Brigitte Régnier found a treatment team that was using an unusual approach of giving chemoradiation before surgery for pancreatic cancer.

Aretha Franklin on January 20 2009
News
August 29, 2018 • 3 Min

Pancreatic Cancer Organizations Join in Mourning Aretha Franklin

Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.

White net mask in close up
Research
August 29, 2018 • 2 Min

Radiotherapy Implant plus Standard Chemotherapy

The OncoSil radiotherapy implant device is being tested on pancreatic cancer in a clinical trial that combines it with standard chemotherapy.

Dr. Ben Z. Stanger
Research
August 24, 2018 • 5 Min

New Research Sheds Light on Hot and Cold Tumors

Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.

Anne Seagren and her husband in their kitchen
Survivor Stories
August 23, 2018 • 1 Min

Don’t Believe the Odds

Anne Seagren is a long-term survivor of pancreatic cancer. Chemotherapy shrank her tumor and made her eligible for a Whipple procedure.

Mary Gillam and her husband and three children standing in front of a Christmas tree.
Survivor Stories
August 21, 2018 • 6 Min

I Have So Much to Live For

Mary Gillam knew that she had to fight after her pancreatic cancer diagnosis. She traveled to where she would get the best treatment and a clinical trial.

Oncology nurse navigator Patricia Gambino
Disease Management
August 16, 2018 • 6 Min

Nurse Navigators Provide a Guide for the Pancreatic Cancer Journey

Are you overwhelmed by your pancreatic cancer diagnosis? Patricia Gambino explains how a nurse navigator can help you through the treatment process.

Elliot Fishman
Research
August 13, 2018 • 5 Min

Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer

Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.

Randall Swan
Survivor Stories
August 8, 2018 • 6 Min

Before And After: My Pancreatic Cancer

Randall Swan did his homework on the best treatments and clinical trial options in order to do battle with pancreatic cancer.

looking down on top of culture test tubes with red tops, against a light blue background
Research
August 3, 2018 • 2 Min

Targeting Tumor Proteins Specific to Pancreatic Cancer Cells

A clinical trial tests the safety and effectiveness of tumor-associated antigen-specific cytotoxic T lymphocytes, which target specific tumor proteins.